Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.

Carcinoma, Hepatocellular / radiotherapy Consensus Development Conferences as Topic Humans Liver Neoplasms / radiotherapy Microspheres Practice Guidelines as Topic Radiometry / standards Radiopharmaceuticals / standards Radiotherapy / methods Radiotherapy Dosage Yttrium Radioisotopes / standards
Hepatocellular carcinoma Liver cancer Radioembolization Yttrium-90

Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 19 02 2019
accepted: 17 04 2019
pubmed: 18 5 2019
medline: 9 7 2020
entrez: 18 5 2019
Statut: ppublish

Résumé

The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.

Identifiants

DOI: 10.1007/s00259-019-04340-5 PMID: 31098749
pubmed: 31098749
doi: 10.1007/s00259-019-04340-5
pii: 10.1007/s00259-019-04340-5
doi:

Substances chimiques

Radiopharmaceuticals 0
Yttrium Radioisotopes 0
Yttrium-90 1K8M7UR6O1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1695-1704

Références

J Vasc Interv Radiol. 2002 Sep;13(9 Pt 2):S223-9
pubmed: 12354840
J Nucl Med. 2006 Jul;47(7):1209-11
pubmed: 16818957
J Vasc Interv Radiol. 2006 Aug;17(8):1251-78
pubmed: 16923973
J Vasc Interv Radiol. 2006 Sep;17(9):1425-39
pubmed: 16990462
Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):571-92
pubmed: 17516113
Radiographics. 2008 Jan-Feb;28(1):81-99
pubmed: 18203932
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
J Nucl Med. 2009 Mar;50(3):477-84
pubmed: 19258258
J Vasc Interv Radiol. 2009 May;20(5):606-13
pubmed: 19345589
Gastroenterology. 2010 Jan;138(1):52-64
pubmed: 19766639
Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):163-71
pubmed: 20421150
Q J Nucl Med Mol Imaging. 2011 Apr;55(2):168-97
pubmed: 21386789
Gastroenterology. 2011 Aug;141(2):526-35, 535.e1-2
pubmed: 21664356
Med Phys. 2011 Aug;38(8):4824-45
pubmed: 21928655
Cardiovasc Intervent Radiol. 2012 Oct;35(5):1109-18
pubmed: 22037709
J Hepatol. 2012 Aug;57(2):421-9
pubmed: 22504332
Hepatology. 2013 May;57(5):1826-37
pubmed: 22911442
J Hepatol. 2013 Jan;58(1):73-80
pubmed: 23000237
Hepatology. 2013 Mar;57(3):1078-87
pubmed: 23225191
J Nucl Med. 2013 Apr;54(4):516-22
pubmed: 23447653
Ann Surg Oncol. 2013 Aug;20(8):2518-25
pubmed: 23494107
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1057-68
pubmed: 23613103
J Hepatol. 2013 Nov;59(5):1029-36
pubmed: 23811303
J Vasc Interv Radiol. 2013 Nov;24(11):1743-5
pubmed: 24160828
J ICRU. 2011 Apr;11(1):1-31
pubmed: 24174259
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):634-8
pubmed: 24477451
Hepatology. 2014 Jul;60(1):192-201
pubmed: 24691943
J Vasc Interv Radiol. 2014 Jul;25(7):1067-73
pubmed: 24837982
J Nucl Med. 2014 Jul;55(7):1215-6
pubmed: 24898027
J Natl Compr Canc Netw. 2014 Aug;12(8):1152-82
pubmed: 25099447
Front Oncol. 2014 Aug 19;4:210
pubmed: 25191640
J Nucl Med. 2015 Mar;56(3):339-46
pubmed: 25678490
J Nucl Med. 2015 Aug;56(8):1157-62
pubmed: 26089551
Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1718-1738
pubmed: 26112387
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2038-44
pubmed: 26194715
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):559-75
pubmed: 26338177
J Surg Oncol. 2016 Jul;114(1):99-105
pubmed: 27103352
Eur Radiol. 2017 Feb;27(2):526-535
pubmed: 27277261
Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2353-2359
pubmed: 27315059
J Vasc Interv Radiol. 2016 Aug;27(8):1123-9
pubmed: 27321889
Liver Int. 2017 Jan;37(1):101-110
pubmed: 27514012
J Vasc Interv Radiol. 2016 Sep;27(9):1453-1456
pubmed: 27566430
Gastroenterology. 2016 Dec;151(6):1155-1163.e2
pubmed: 27575820
Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):888-896
pubmed: 27623307
Radiology. 2017 Jun;283(3):895-905
pubmed: 27930089
EJNMMI Res. 2017 Dec;7(1):2
pubmed: 28058660
J Vasc Interv Radiol. 2017 May;28(5):722-730.e1
pubmed: 28238581
J Vasc Interv Radiol. 2017 Jun;28(6):777-785.e1
pubmed: 28365172
J Vasc Interv Radiol. 2017 Sep;28(9):1210-1223.e3
pubmed: 28669744
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2195-2202
pubmed: 28812136
Hepatology. 2018 Mar;67(3):873-883
pubmed: 28833344
Lancet Oncol. 2017 Dec;18(12):1624-1636
pubmed: 29107679
Med Phys. 2018 Feb;45(2):875-883
pubmed: 29172243
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):392-401
pubmed: 29177870
Hepatology. 2018 Oct;68(4):1429-1440
pubmed: 29194711
J Nucl Med. 2018 Jul;59(7):1042-1048
pubmed: 29217739
World J Hepatol. 2017 Dec 28;9(36):1372-1377
pubmed: 29359022
J Clin Oncol. 2018 Jul 1;36(19):1913-1921
pubmed: 29498924
Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):358-365
pubmed: 29559288
Cardiovasc Intervent Radiol. 2018 Sep;41(9):1363-1372
pubmed: 29651580
Radiology. 2018 Jun;287(3):1050-1058
pubmed: 29688155
Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2110-2121
pubmed: 29948107
Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):451-461
pubmed: 30191875

Auteurs

Riad Salem (R)

Department of Radiology, Northwestern University, 676 N. St. Clair, Suite 800, Chicago, IL, 60611, USA. r-salem@northwestern.edu.
ORCID: 0000-0001-9745-1825

Siddharth A Padia (SA)

Department of Radiology, University of California-Los Angeles, Los Angeles, CA, USA.

Marnix Lam (M)

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Jon Bell (J)

Department of Radiology, The Christie, Manchester, UK.

Carlo Chiesa (C)

Department of Nuclear Medicine, Fondazione IRCCS Istituto Nazionale Tumouri, Milan, Italy.

Kirk Fowers (K)

BTG International, West Conshohocken, PA, USA.

Bonnie Hamilton (B)

BTG International, West Conshohocken, PA, USA.

Joseph Herman (J)

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

S Cheenu Kappadath (SC)

Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Thomas Leung (T)

Comprehensive Oncology Centre, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong.

Lorraine Portelance (L)

Department of Radiation Oncology, University of Miami, Miami, FL, USA.

Daniel Sze (D)

Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, USA.

Etienne Garin (E)

Univ Rennes, INSERM, INRA, Centre de Lutte contre le Cancer Eugène Marquis, Institut NUMECAN (Nutrition Metabolisms and Cancer), F-35000, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Tumeurs du foie › Carcinome hépatocellulaire › Clinical and dosimetric considerations for...
questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Congrès comme sujet › Conférences de consensus comme sujet › Clinical and dosimetric considerations for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Clinical and dosimetric considerations for...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies du foie › Tumeurs du foie › Clinical and dosimetric considerations for...
questionsmedicales.fr › Équipement et fournitures › Microsphères › Clinical and dosimetric considerations for...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › Clinical and dosimetric considerations for...
questionsmedicales.fr › Techniques d'investigation › Radiométrie › Clinical and dosimetric considerations for...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › Clinical and dosimetric considerations for...
questionsmedicales.fr › Thérapeutique › Radiothérapie › Clinical and dosimetric considerations for...
questionsmedicales.fr › Thérapeutique › Radiothérapie › Dosimétrie en radiothérapie › Clinical and dosimetric considerations for...
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Terres rares › Yttrium › Isotopes de l'yttrium › Radio-isotopes de l'yttrium › Clinical and dosimetric considerations for...